James F. Oliviero III, CEO, President and Director at Checkpoint Therapeutics, Inc. (CKPT), sold 237,580 shares at $3.51 ($825K) on 2021-02-04, disclosed to the SEC on 2021-02-05.
Open-market sale of $825k CKPT by CEO, President and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.51 | 70,000 | $246K | 29.8% |
| 2 | $3.51 | 70,000 | $246K | 29.8% |
| 3 | $3.42 | 48,790 | $167K | 20.2% |
| 4 | $3.42 | 48,790 | $167K | 20.2% |
| Total | $3.47 avg | 237,580 | $825K | 100% |
| Filing → |
| CKPT | SELL | 2024-12-20 | $6.1M | — | Filing → |
| CKPT | SELL | 2024-06-28 | $101K | — | Filing → |
| CKPT | SELL | 2024-03-01 | $12K | — | Filing → |